title: Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.
abstract: Based on in vitro data, protein-bound uremic retention solutes have increasingly been recognized to play a pathophysiological role in the uremic syndrome. p-Cresol, a representative of this group of molecules, has been shown to be implicated in uremic immunodeficiency and endothelial dysfunction, potentially linking its serum levels to mortality. Thus far, however, no clinical information on this issue is available. To determine the relationship between p-cresol and all-cause mortality, 175 prevalent hemodialysis (HD) patients were enrolled in a prospective study. At baseline, serum levels of the water-soluble solutes urea, creatinine, and phosphate, the middle molecule beta2-microglobulin, total and free concentrations of the protein-bound solute p-cresol, and several risk factors for mortality were evaluated. During a median follow-up of 34 months, 60 patients died. Baseline comorbidity (Davies score) (hazard ratio (HR), 1.49; 95% confidence interval (95% CI), 1.19-1.86), impaired nutritional status (HR, 4.22; 95% CI, 2.15-8.29), time since initiation of dialysis (HR, 0.98; 95% CI, 0.97-1.00), and higher free concentrations of the protein-bound solute p-cresol (HR, 2.28; 95% CI, 1.12-4.64) were independently associated with mortality (multivariate Cox proportional hazards analysis). Our data suggest that free serum levels of p-cresol, a representative of the protein-bound uremic retention solutes, are associated with mortality in HD patients. These findings may encourage nephrologists to widen their field of interest beyond the scope of small water-soluble uremic solutes and middle molecules.
authors.affiliation: Department of Medicine, Division of Nephrology, University Hospital Gasthuisberg, Leuven, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Bammens
authors.forename: P
authors.initials: P
authors.lastname: Evenepoel
authors.forename: H
authors.initials: H
authors.lastname: Keuleers
authors.forename: K
authors.initials: K
authors.lastname: Verbeke
authors.forename: Y
authors.initials: Y
authors.lastname: Vanrenterghem
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D016001:Confidence Intervals; D003404:Creatinine / Q000097:blood; D003408:Cresols / Q000097:blood*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000097:blood; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D011446:Prospective Studies; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000097:blood* / Q000401:mortality* / Q000503:physiopathology / Q000628:therapy; D012307:Risk Factors; D014118:Toxins, Biological / Q000097:blood; D014508:Urea / Q000097:blood
chemical_list: D003408:Cresols; D010710:Phosphates; D014118:Toxins, Biological; C026865:uremia middle molecule toxins; C032538:4-cresol; D014508:Urea; D003404:Creatinine